{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:35:21Z","timestamp":1792722921478,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> The goal of this study was to reveal the clinical manifestations of nonneutropenic invasive pulmonary aspergillosis (IPA), which are different from those of neutropenic patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The clinical data of patients with nonneutropenic IPA were collected at the Department of Respiratory and Critical Care Medicine, Jinling Hospital, from February 2009 to November 2019. We analyzed the general conditions, clinical manifestations, imaging findings, and laboratory tests of these IPA patients.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 116 patients with nonneutropenic IPA (31 proven and 85 probable) were included. They had an average age of 59.8 years. The most common underlying disease was chronic obstructive pulmonary disease (COPD, <jats:italic>n<\/jats:italic> = 33). The common clinical symptoms included cough (93.1%, <jats:italic>n<\/jats:italic> = 108), expectoration (59.5%, <jats:italic>n<\/jats:italic> = 69), fever (57.8%, <jats:italic>n<\/jats:italic> = 67), hemoptysis (30.2%, <jats:italic>n<\/jats:italic> = 35), and dyspnea (40.5%, <jats:italic>n<\/jats:italic> = 47). The common CT imaging manifestations included consolidation (47.4%, <jats:italic>n<\/jats:italic> = 55), cavities (47.4%, <jats:italic>n<\/jats:italic> = 55), air crescent sign (14.7%, <jats:italic>n<\/jats:italic> = 17), and nodules (8.6%, <jats:italic>n<\/jats:italic> = 10). Multiple lesions (74.1%, <jats:italic>n<\/jats:italic> = 86) were more common than single lesions (17.2%, <jats:italic>n<\/jats:italic> = 20) and diffuse lesions (8.6%, <jats:italic>n<\/jats:italic> = 10). The positive rate of laboratory tests was 88.2% (30\/34) for BALF galactomannan (GM), 55.4% (56\/101) for serum GM, 45.3% (48\/106) for 1,3-\u03b2-D-glucan (BDG), 43.3% (46\/106) for sputum culture, and 36.4% (20\/55) for BALF culture. Patients who had high serum GM level [GM optical density index (ODI) &amp;gt;1] were more likely to have severe respiratory symptoms and higher serum ferritin. Further investigation showed that there was a positive correlation between serum GM level and serum ferritin level.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The clinical symptoms and radiological manifestations of nonneutropenic IPA are diverse and often lead to delayed diagnosis. It is important to become more vigilant of aspergillosis in nonneutropenic patients in order to achieve early diagnosis and treatment and to reduce mortality.<\/jats:p>","DOI":"10.3389\/fmed.2021.631461","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T07:10:22Z","timestamp":1613373022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["The Clinical Characteristics of Patients With Nonneutropenic Invasive Pulmonary Aspergillosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Lulu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2165\/00003495-200767110-00004","article-title":"Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients","volume":"67","author":"Maschmeyer","year":"2007","journal-title":"Drugs."},{"key":"B2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax."},{"key":"B3","doi-asserted-by":"publisher","first-page":"28263","DOI":"10.1074\/jbc.M109.009225","article-title":"Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition","volume":"284","author":"Ma","year":"2009","journal-title":"J Biol Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive","volume":"46","author":"Pauw","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1128\/JCM.00345-17","article-title":"Diagnostic value of the galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with non-neutropenic invasive pulmonary aspergillosis","volume":"55","author":"Zhou","year":"2017","journal-title":"J Clin Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1111\/ejh.12421","article-title":"Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation","volume":"94","author":"Dadwal","year":"2014","journal-title":"Eur J Haematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e00140","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and Aspergillosis in 2019","volume":"33","author":"Jean-Paul","year":"2019","journal-title":"Clin Microbiol Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3685261","DOI":"10.1155\/2017\/3685261","article-title":"Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis with nonneutropenic patients","volume":"2017","author":"Zhuang","year":"2017","journal-title":"Can Respir J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2169\/internalmedicine.53.2381","article-title":"Diagnostic value of the serum galacromannan and (1,3)-\u03b2-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"53","author":"Cai","year":"2014","journal-title":"Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/cdd.2010.68","article-title":"A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007","volume":"34","author":"Liu","year":"2011","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi."},{"key":"B12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/thoraxjnl-2015-207305","article-title":"The ambitious \u201c95-95 by 2025\u201d roadmap for the diagnosis and management of fungal diseases","volume":"70","author":"Denning","year":"2015","journal-title":"Thorax."},{"key":"B13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary aspergillosis : a clinical review","volume":"20","author":"Kousha","year":"2011","journal-title":"Eur Respir Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1034\/j.1600-0455.2002.430310.x","article-title":"Early chest radiography and CT in the diagnosis management and outcome of invasive pulmoanry aspergillosis","volume":"43","author":"Hauggaard","year":"2002","journal-title":"Acta Radiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1164\/rccm.201403-0431OC","article-title":"Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease","volume":"190","author":"Affolter","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jinf.2018.05.001","article-title":"Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples","volume":"77","author":"Heldt","year":"2018","journal-title":"J Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","article-title":"Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases","volume":"190","author":"Prattes","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1128\/JCM.00110-15","article-title":"Aspergillus lateral-flow device and qPCR testing in bronchoalveolar lavage fluid : a combination biomarker approach for the clinical diagnosis of invasive pulmonary aspergillosis","volume":"53","author":"Johnson","year":"2015","journal-title":"J Clin Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"52","author":"Hoenig","year":"2014","journal-title":"J Clin Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/cncr.22863","article-title":"Serum aspergillus galactomannan antigen values stongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer","volume":"110","author":"Woods","year":"2007","journal-title":"Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1128\/JCM.00680-10","article-title":"Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis","volume":"48","author":"Koo","year":"2010","journal-title":"J Clin Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.patbio.2011.10.011","article-title":"Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis","volume":"60","author":"Hadrich","year":"2012","journal-title":"Pathol Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.bmt.1704628","article-title":"Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis","volume":"34","author":"Altes","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cncr.22909","article-title":"Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation","volume":"110","author":"Kontoyiannis","year":"2007","journal-title":"Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/myc.12773","article-title":"Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high- - risk haematology patients","volume":"61","author":"Hammarstr\u00f6m","year":"2018","journal-title":"Mycoses."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/bmt.2009.383","article-title":"Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients : the role of iron overload","volume":"45","author":"Ozyilmaz","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.2337\/diacare.22.12.1978","article-title":"Diabetes and serum ferritin concentration among U.S. adults","volume":"22","author":"Ford","year":"1999","journal-title":"Diabetes Care."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.631461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T07:10:24Z","timestamp":1613373024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.631461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":28,"alternative-id":["10.3389\/fmed.2021.631461"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.631461","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"article-number":"631461"}}